Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-25 @ 8:16 PM
Study NCT ID:
NCT00066469
Status:
COMPLETED
Last Update Posted:
2019-08-06
First Post:
2003-08-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
Sponsor:
Children's Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
2009-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2003-08-06
First Submit QC Date:
None
Study First Post Date:
2003-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-17
Results First Submit QC Date:
None
Results First Post Date:
2014-01-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-25
Last Update Post Date:
2019-08-06
Last Update Post Date Type:
ACTUAL